Dov Elefant

Insider Reports History

Identity
Location
Englewood Cliffs, NJ
SEC record
Reporting signature
/s/ Kathy Lee-Sepsick, Attorney-in-fact
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Dov Elefant:

Form 4 holding Chief Financial Officer

FEMASYS INC

Security class
Common Stock
Shares / value
58,436
Estimated value
$52,592
Report date
27 Aug 2025
Price
$0.9000
Ownership
Direct
Form 4 holding Chief Financial Officer

Cellectar Biosciences, Inc.

Security class
Stock option (right to buy)
Shares / value
422,000
Estimated value
Report date
25 Jan 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

FEMASYS INC

Security class
Restricted Stock Units
Shares / value
169,000
Estimated value
Report date
19 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

FEMASYS INC

Security class
Common Warrants (right to buy)
Shares / value
38,828
Estimated value
Report date
27 Aug 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Dov Elefant

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .